behavioral neurology and neuropsychiatry fellowship

X. Active State Licensure
Texas H3840
Page 16
XI. PUBLICATIONS
1. Schulz PE, Weiner SP, Belmont J, Fishman M. Basal ganglia calcifications in a case of
biotinidase deficiency. Neurology 1988; 38 (8): 1326–1328.
2. Sanders WE Jr., Cheirif J, Desir R, Zoghbi WA, Hoyt BD, Schulz PE, Quinones MA. Contrast
opacification of left ventricular myocardium following intravenous administration of sonicated
albumin microspheres. Am Heart J 1991; 122 (6): 1660–1665.
3. Schulz PE, Weiner SP, Haber LM, Armstrong DD, Fishman MA. Neurologic complications of fat
emulsion therapy. Ann. Neurol. 1994; 35(5): 628–630.
4. Schulz PE, Cook EP, Johnston D. Changes in paired-pulse facilitation suggest presynaptic
involvement in long-term potentiation. J. Neurosci. 1994; 14(9): 5325–5337.
5. Schulz PE, Cook EP, Johnston D. Using paired-pulse facilitation to probe the mechanisms for
long-term potentiation (LTP). J Physiol (Paris) 1995; 89:3–9.
6. White PA, Guyton L, Schulz PE. Emerging Concepts in Pain Mechanisms: Neuropeptides,
Neurotrophins, and Neuronal Plasticity. In Current Neurology (Vol. 17), Appel SH ed., IOS Press,
Washington DC, 1997, 293–319.
7. Sano M, Ernesto C, Klauber MR, Schafer K, Woodbury P, Thomas R, Grundman M, Growdon J,
Thal LJ. Rationale and design of a multicenter study of selegiline and alpha-tocopherol in the
treatment of Alzheimer disease using novel clinical outcomes. Alzheimer's Disease Cooperative
Study. Alzheimer Dis Assoc Disord 1996 Fall; 10(3): 132-40. Baylor Co-investigator in this
multicenter trial.
8. Sano M, Ernesto C, Thomas RG, Klauber MR, Schafer K, Grundman M, Woodbury P, Growdon
J, Cotman CW, Pfeiffer E, Schneider LS, and Thal LJ for the members of the Alzheimer's Disease
Cooperative Study. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for
Alzheimer's Disease. N Engl J Med. 1997; 336 (17): 1216–1222. Baylor Co-investigator in this
multicenter trial.
9. Ferris SH, Mackell JA, Mohs R, Schneider LS, Galasko D, Whitehouse PJ, Schmitt FA, Sano M,
Thomas RG, Ernesto C, Grundman M, Schafer K, Thal LJ. A multicenter evaluation of new
treatment efficacy instruments for Alzheimer's disease clinical trials: overview and general results.
The Alzheimer's Disease Cooperative Study. Alzheimer Dis Assoc Disord 1997; 11 Suppl 2:S1-
12. Baylor Co-investigator in this multicenter trial.
10. Mackell JA, Ferris SH, Mohs R, Schneider L, Galasko D, Whitehouse P, Schmitt F, Sano M, Thal
LJ. Multicenter evaluation of new instruments for Alzheimer's disease clinical trials: summary of
results. The Alzheimer's Disease Cooperative Study. Alzheimer Dis Assoc Disord 1997; 11
Suppl 2:S65–9. Baylor Co-investigator in this multicenter trial.
11. Schneider LS, Olin JT, Doody RS, Clark CM, Morris JC, Reisberg B, Schmitt FA, Grundman M,
Thomas RG, Ferris SH. Validity and reliability of the Alzheimer's Disease Cooperative Study-
Clinical Global Impression of Change. The Alzheimer's Disease Cooperative Study. Alzheimer
Dis Assoc Disord 1997; 11 Suppl 2:S22–32. Baylor Co-investigator in this multicenter trial.
12. Schulz PE. Long-term potentiation involves increases in the probability of neurotransmitter
release. Proc Natl Acad of Sci USA 1997; 94: 5888–5893.
13. Schulz PE, Fitzgibbons JC. Differing mechanisms of expression for short- and long-term
potentiation. J Neurophysiol. 1997; 78: 321–334.
14. Knopman DS, Berg JD, Thomas R, Grundman M, Thal LJ, Sano M. Nursing home placement is
related to dementia progression: experience from a clinical trial. Alzheimer's Disease Cooperative
Study. Neurology 1999 Mar 10; 52(4): 714-8. Baylor Co-investigator in the multicenter trial
from which this data was derived.
15. Mulnard RA, Cotman CW, Kawas C, van Dyck CH, Sano M, Doody R, Koss E, Pfeiffer E, Jin S,
Gamst A, Grundman M, Thomas R, Thal LJ. Estrogen replacement therapy for treatment of mild
to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative
Study. JAMA 2000 Feb 23; 283(8): 1007-15. Baylor Co-investigator in this multicenter trial.
UCNS Program Accreditation Application
Behavioral Neurology & Neuropsychiatry February 2006